Lower Patient Anxiety and Unchanged Levels of Adherence to Hemato-Oncologic Treatment in Response to New Measures to Reduce Hospital Exposure Risk to COVID-19

OBJECTIVE: Hemato-oncology patients are at high risk for morbidity and mortality from coronavirus disease (COVID-19). The resultant heightened anxiety among these patients may negatively affect adherence to therapy and treatment-related outcome. We aimed to assess whether the adoption of precautiona...

Descripción completa

Detalles Bibliográficos
Autores principales: Sarid, Nadav, Mann, Shir, Herishanu, Yair, Perry, Chava, Cohen, Yael C, Passage, Inna, Neaman, Miriam, Benyamini, Noam, Jean, Maayan, Avivi, Irit
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2021
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8122002/
https://www.ncbi.nlm.nih.gov/pubmed/34007160
http://dx.doi.org/10.2147/PPA.S307561

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8122002/
https://www.ncbi.nlm.nih.gov/pubmed/34007160
http://dx.doi.org/10.2147/PPA.S307561

Ejemplares similares